42P Comparing survival outcomes in KRAS G12 vs KRAS G13-mutated metastatic colorectal cancer (mCRC): A 13-year cohort studyRosa M. Quinta‐Ferreira, João Gramaça, Joaquim Mendes et al.|ESMO Open|2025Cited by 0
Baseline biochemical and clinical predictors of castration resistance and survival in metastatic hormone-sensitive prostate cancer treated with first-line androgen receptor pathway inhibitors: A multicenter real-world study.F. Verdasca, João Gramaça, S. Meireles et al.|Journal of Clinical Oncology|2026Cited by 0